Cytoplasmic HDAC3 is an independent prognostic factor for the overall survival and brain metastasis‐free survival of breast cancer patients.Cytoplasmic expression of HDAC3 was further upregulated in the brain metastases compared with the matched primary tumours, while nuclear expression was downregulated. Here, HDAC3 is linked to breast carcinoma.